SAN DIEGO—Dexcom, a manufacturer of continuous glucose monitoring (CGM) sensors, announced that it will stop producing the G6 model of their CGM system starting July 1, 2026.
While supplies may be available through local pharmacies or local medical distributors for a while afterwards, Dexcom said it cannot guarantee availability of the G6 after July 1 and is encouraging everyone who uses the G6 to work with their doctor to upgrade to the G7 as soon as they can.
Dexcom said all current G6 users have been notified of the transition via email.
Dexcom added that this decision was made so the company can better focus on innovation and introducing better and more accurate sensors to the market moving forward.
Compared to the G6, Dexcom’s G7 and G7 15 Day are smaller in size, have a shorter warm-up period and are shown in clinical studies to have better glucose level accuracy. G7 sensors also work with a variety of automated insulin delivery (AID) systems and smart pens. Dexcom said every patient on a G6 will be upgraded to a G7 system.
In order to upgrade to a G7 ahead of the discontinuation of the G6:
- Patients will need to ask their doctor for a prescription for the G7.
- For many people with insurance, CGMs are covered through pharmacy benefits, so an updated prescription should go to your pharmacy.
- For others with insurance, CGMs are fulfilled through durable medical equipment (DME) distributors. These users should contact their medical distributor directly to get started.